187 related articles for article (PubMed ID: 31292251)
1. LAP
Rey LM; Gil JÁ; Mateus J; Rodríguez LS; Rondón MA; Ángel J; Franco MA
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292251
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model.
Ward RL
Viral Immunol; 2003; 16(1):17-24. PubMed ID: 12725685
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism.
Oida T; Zhang X; Goto M; Hachimura S; Totsuka M; Kaminogawa S; Weiner HL
J Immunol; 2003 Mar; 170(5):2516-22. PubMed ID: 12594277
[TBL] [Abstract][Full Text] [Related]
5. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
6. Flagellin is a Th1 polarizing factor for human CD4
Labastida-Conde RG; Ramírez-Pliego O; Peleteiro-Olmedo M; Lopez-Guerrero DV; Badillo-Godinez OD; Gutiérrez-Xicoténcatl ML; Rosas-Salgado G; González-Fernández Á; Esquivel-Guadarrama FR; Santana MA
Vaccine; 2018 Jul; 36(29):4188-4197. PubMed ID: 29891347
[TBL] [Abstract][Full Text] [Related]
7. Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.
Chattha KS; Vlasova AN; Kandasamy S; Rajashekara G; Saif LJ
J Immunol; 2013 Sep; 191(5):2446-56. PubMed ID: 23918983
[TBL] [Abstract][Full Text] [Related]
8. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.
Yuan L; Wen K; Azevedo MS; Gonzalez AM; Zhang W; Saif LJ
Vaccine; 2008 Jun; 26(26):3322-31. PubMed ID: 18456375
[TBL] [Abstract][Full Text] [Related]
10. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
11. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
[TBL] [Abstract][Full Text] [Related]
12. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
Azevedo MP; Vlasova AN; Saif LJ
Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
[TBL] [Abstract][Full Text] [Related]
13. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model.
Kandasamy S; Chattha KS; Vlasova AN; Saif LJ
Vaccine; 2014 Feb; 32(7):816-24. PubMed ID: 24380684
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccines: how they work or don't work.
Ward RL
Expert Rev Mol Med; 2008 Feb; 10():e5. PubMed ID: 18267049
[TBL] [Abstract][Full Text] [Related]
15. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
16. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
17. Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.
Meier AF; Suter M; Schraner EM; Humbel BM; Tobler K; Ackermann M; Laimbacher AS
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212334
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccines and vaccination in Latin America.
Linhares AC; Bresee JS
Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
